Evaluation of Tonabersat for DME - Trial NCT05727891
Access comprehensive clinical trial information for NCT05727891 through Pure Global AI's free database. This Phase 2 trial is sponsored by Jaeb Center for Health Research and is currently Not yet recruiting. The study focuses on Diabetic Macular Edema. Target enrollment is 128 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Jaeb Center for Health Research
Timeline & Enrollment
Phase 2
Mar 01, 2023
Mar 01, 2025
Primary Outcome
Mean change in central subfield thickness
Summary
This randomized clinical trial will evaluate the effect of tonabersat compared with placebo
 on central subfield thickness (CST) in eyes with center-involved diabetic macular edema
 (CI-DME) and good visual acuity.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05727891
Non-Device Trial